The hepatocellular carcinoma Early Recurrence Score (<scp>ERS</scp>)—Ready for clinical implementation?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The hepatocellular carcinoma Early Recurrence Score (ERS)—Ready for clinical implementation?

Published:2023-10-17 Issue:11 Volume:43 Page:2346-2347
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Reeves Helen L.¹²^ORCID,Hammond John S.³

Affiliation:

1. Newcastle University Translational and Clinical Research Institute, The Medical School Newcastle‐upon‐Tyne UK

2. The Liver Unit Freeman Hospital Newcastle‐upon‐Tyne UK

3. Department of HPB & Transplantation Surgery Freeman Hospital Newcastle‐upon‐Tyne UK

Funder

Cancer Research UK

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15741

Reference7 articles.

1. Clinical Prediction Models

2. Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist

3. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement

4. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection

5. Time to recurrence, but not recurrence-free survival, should be the endpoint used to predict early recurrence after HCC resection

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP